Neuroprotective Strategies in a Model of Chronic Glutamate‐Mediated Motor Neuron Toxicity

Abstract: A dramatic loss of glutamate transport has been observed in sporadic amyotrophic lateral sclerosis and has been postulated to contribute to the disease. Experimentally, this hypothesis was corroborated by mimicking the chronic loss of glutamate transport in post‐natal rat spinal cord organotypic cultures through the use of glutamate transport inhibitors. This system is characterized by a relatively selective slow loss of ventral horn motor neurons resulting from glutamate transport inhibition. In this study, spinal cord organotypic cultures were used to test various drugs to evaluate their neuroprotective properties against this slow glutamate‐mediated neurotoxicity. The most potent neuroprotectants were drugs that altered glutamate neurotransmission, including non‐NMDA receptor antagonists (GYKI‐52466, PD144216, and PD139977) and drugs that could block presynaptic release or synthesis (riluzole and gabapentin). In addition, some antioxidants (U83836E and N‐t‐butyl‐α‐phenylnitrone) and inhibitors of nitric oxide synthesis (NG‐monomethyl‐l‐arginine acetate) were modestly neuroprotective. The calcium endonuclease inhibitor aurintricarboxylic acid and the calcium release inhibitor dantrolene also provided partial motor neuron protection. However, several antioxidants and calcium channel antagonists had no excitotoxic neuroprotectant activity. This system provides a preclinical screening method for the burgeoning number of drugs postulated for clinical trials in motor neuron disease and a model to evaluate the mechanisms of chronic glutamate toxicity.

[1]  J. Dykens.  Isolated Cerebral and Cerebellar Mitochondria Produce Free Radicals when Exposed to Elevated Ca2+ and Na+: Implications for Neurodegeneration , 1994, Journal of neurochemistry.

[2]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[3]  C. Taylor,et al.  Emerging perspectives on the mechanism of action of gabapentin , 1994, Neurology.

[4]  J. Rothstein,et al.  Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Volterra,et al.  Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  P. Sindou,et al.  Neuroprotective effects of riluzole in ALS CSF toxicity. , 1994, Neuroreport.

[7]  W. H. Yu,et al.  Nitric oxide synthase in motor neurons after axotomy. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[8]  J. Long,et al.  Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury. , 1994, The Journal of pharmacology and experimental therapeutics.

[9]  V. Meininger,et al.  A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. , 1994, The New England journal of medicine.

[10]  T. Murphy,et al.  Rapid Communication: Oxidative Stress Induces Apoptosis in Embryonic Cortical Neurons , 1994, Journal of neurochemistry.

[11]  Robert H. Brown,et al.  Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral Sclerosis , 1993, Journal of neurochemistry.

[12]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[13]  Kahori Yamada,et al.  Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  T. H. Johansen,et al.  A novel non-NMDA receptor antagonist shows selective displacement of low-affinity [3H]kainate binding. , 1993, European journal of pharmacology.

[15]  M. Billiard,et al.  Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis , 1993, Acta neurologica Scandinavica.

[16]  D. Schoepp,et al.  Aurintricarboxylic Acid Prevents NMDA‐Mediated Excitotoxicity: Evidence for Its Action as an NMDA Receptor Antagonist , 1993, Journal of neurochemistry.

[17]  J. Dubinsky,et al.  Aurintricarboxylic Acid Protects Hippocampal Neurons from Glutamate Excitotoxicity In Vitro , 1993, Journal of neurochemistry.

[18]  M. E. Lewis,et al.  Aurintricarboxylic Acid Protects Hippocampal Neurons from NMDA‐and Ischemia‐Induced Toxicity In Vivo , 1993, Journal of neurochemistry.

[19]  G. Mentis,et al.  Motoneurons destined to die are rescued by blocking n-methyl-d-aspartate receptors by MK-801 , 1993, Neuroscience.

[20]  M. Roisin,et al.  Effect of potassium channel modulators on the release of glutamate induced by ischaemic-like conditions in rat hippocampal slices , 1993, Neuroscience Letters.

[21]  Wutian Wu,et al.  Inhibition of nitric oxide synthase reduces motoneuron death due to spinal root avulsion , 1993, Neuroscience Letters.

[22]  A. Schousboe,et al.  Excitatory Amino Acid‐Mediated Cytotoxicity and Calcium Homeostasis in Cultured Neurons , 1993, Journal of neurochemistry.

[23]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[24]  J. Olney,et al.  A benzodiazepine recognition site associated with the non-NMDA glutamate receptor , 1993, Neuron.

[25]  M. Rogawski,et al.  GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses , 1993, Neuron.

[26]  G. Edwards,et al.  The pharmacology of ATP-sensitive potassium channels. , 1993, Annual review of pharmacology and toxicology.

[27]  E. Stefani,et al.  Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. , 1992, The New England journal of medicine.

[28]  S. L. Dun,et al.  Nitric oxide synthase immunoreactivity in rat spinal cord , 1992, Neuroscience Letters.

[29]  D. Choi.  Excitotoxic cell death. , 1992, Journal of neurobiology.

[30]  J. Coyle,et al.  The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801 , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  A. Volterra,et al.  High Sensitivity of Glutamate Uptake to Extracellular Free Arachidonic Acid Levels in Rat Cortical Synaptosomes and Astrocytes , 1992, Journal of neurochemistry.

[32]  A. Doble,et al.  Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on d[3H]aspartate release from cultured cerebellar granule cells , 1992, Neuroscience Letters.

[33]  J. Olney,et al.  Excitotoxicity in the embryonic chick spinal cord , 1991, Annals of neurology.

[34]  L. Greene,et al.  Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity , 1991, The Journal of cell biology.

[35]  S. Heinemann,et al.  Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition , 1991, Science.

[36]  G. McBean.  Intrastriatal injection of dl-α-aminoadipate reduces kainate toxicity in vitro , 1990, Neuroscience.

[37]  A. Plaitakis.  Glutamate dysfunction and selective motor neuron degeneration inamyotrophic lateral sclerosis: A hypothesis , 1990, Annals of neurology.

[38]  J. Coyle,et al.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[39]  A. Eisen,et al.  Amyotrophic lateral sclerosis: Amino acid levels in plasma and cerebrospinal fluid , 1990, Annals of neurology.

[40]  A. Faden,et al.  Comparison of the neuroprotective effects of the N-methyl-D-aspartate antagonist MK-801 and the opiate-receptor antagonist nalmefene in experimental spinal cord ischemia. , 1990, Archives of neurology.

[41]  M. Lazdunski,et al.  Glucose, sulfonylureas, and neurotransmitter release: role of ATP-sensitive K+ channels. , 1990, Science.

[42]  D. Attwell,et al.  Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells , 1989, Nature.

[43]  J. Garthwaite,et al.  A Kainate Receptor Linked to Nitric Oxide Synthesis from Arginine , 1989, Journal of neurochemistry.

[44]  D. Choi,et al.  Delayed rescue of N-methyl-D-aspartate receptor-mediated neuronal injury in cortical culture. , 1989, The Journal of pharmacology and experimental therapeutics.

[45]  A. Guidotti,et al.  Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death. , 1989, Molecular pharmacology.

[46]  M. Lazdunski,et al.  Antidiabetic sulfonylureas: localization of binding sites in the brain and effects on the hyperpolarization induced by anoxia in hippocampal slices , 1989, Brain Research.

[47]  M. Lazdunski,et al.  Characterization, purification, and affinity labeling of the brain [3H]glibenclamide-binding protein, a putative neuronal ATP-regulated K+ channel. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[48]  E. J. Fletcher,et al.  Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro , 1988, British journal of pharmacology.

[49]  E. Costa,et al.  Activation of N-methyl-D-aspartate-sensitive glutamate receptors stimulates arachidonic acid release in primary cultures of cerebellar granule cells , 1988, Neuropharmacology.

[50]  J. Caroscio,et al.  Abnormal glutamate metabolism in amyotrophic lateral sclerosis , 1987, Annals of neurology.

[51]  J. Garthwaite,et al.  Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: Dependence on calcium concentration , 1986, Neuroscience Letters.

[52]  R. Ockner,et al.  Modulation of membrane transport by free fatty acids: inhibition of synaptosomal sodium-dependent amino acid uptake. , 1983, Biochemistry.

[53]  P. Chan,et al.  Reductions of Γ‐Aminobutyric Acid and Glutamate Uptake and (Na++ K+)‐ATPase Activity in Brain Slices and Synaptosomes by Arachidonic Acid , 1983, Journal of neurochemistry.

[54]  Roger L. Black,et al.  Goodman and Gilman's The Pharmacological Basis of Therapeutics , 1991 .

[55]  F. Fonnum,et al.  A rapid radiochemical method for the determination of choline acetyltransferase , 1975, Journal of neurochemistry.

[56]  E. De Nito,et al.  [The pharmacology of ATP]. , 1953, Il Policlinico. Sezione pratica.